Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC.
| Image |  |
|---|---|
| Description | scientific article published on 26 March 2018 |
| Author/s |
author: Letizia Gnetti Paola Bordi Marcello Tiseo Roberta Minari Alessandro Leonetti |
| Publication date | March 27, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |